These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1381567)

  • 1. Substance P, thyrotropin-releasing hormone, and monoamine metabolites in cerebrospinal fluid in sleep apnea patients.
    Gislason T; Hedner J; Terenius L; Bisette G; Nemeroff CB
    Am Rev Respir Dis; 1992 Sep; 146(3):784-6. PubMed ID: 1381567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome.
    Eriksson E; Alling C; Andersch B; Andersson K; Berggren U
    Neuropsychopharmacology; 1994 Nov; 11(3):201-13. PubMed ID: 7532413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
    Yoshino K
    No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine metabolites in cerebrospinal fluid during acute cerebral ischemia.
    Tang HZ; Lu XF; Wang KJ; Ou YS; Huang YQ
    Chin Med J (Engl); 1989 Jan; 102(1):18-23. PubMed ID: 2475306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
    Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH
    Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The concentrations of monoamine metabolites and neuropeptides in the cerebrospinal fluid of obese women with different body fat distribution.
    Strömbom U; Krotkiewski M; Blennow K; Månsson JE; Ekman R; Björntorp P
    Int J Obes Relat Metab Disord; 1996 Apr; 20(4):361-8. PubMed ID: 8680464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
    Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamine metabolites level in CSF is related to the 5-HTT gene polymorphism in treatment-resistant depression.
    Kishida I; Aklillu E; Kawanishi C; Bertilsson L; Agren H
    Neuropsychopharmacology; 2007 Oct; 32(10):2143-51. PubMed ID: 17299512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central nervous system monoamine correlates of social dominance in cynomolgus monkeys (Macaca fascicularis).
    Kaplan JR; Manuck SB; Fontenot MB; Mann JJ
    Neuropsychopharmacology; 2002 Apr; 26(4):431-43. PubMed ID: 11927168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers.
    De Bellis MD; Geracioti TD; Altemus M; Kling MA
    Biol Psychiatry; 1993 Apr 15-May 1; 33(8-9):636-41. PubMed ID: 7687151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
    Fujimoto A; Nagao T; Ebara T; Sato M; Otsuki S
    Biol Psychiatry; 1983 Oct; 18(10):1141-52. PubMed ID: 6197099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid.
    Blennow K; Wallin A; Gottfries CG; Månsson JE; Svennerholm L
    J Neural Transm Park Dis Dement Sect; 1993; 5(1):5-15. PubMed ID: 7679905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamines in the brain cerebrospinal fluid of facial pain patients.
    Bouckoms AJ; Sweet WH; Poletti C; Lavori P; Carr D; Matson W; Gamache P; Aronin N
    Anesth Prog; 1992; 39(6):201-8. PubMed ID: 7504420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF concentration gradients of monoamine metabolites in patients with hydrocephalus.
    Malm J; Kristensen B; Ekstedt J; Wester P
    J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1026-33. PubMed ID: 7522267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study of clinical pictures and monoamine metabolism of Gilles de la Tourette syndrome].
    Takano K; Ishiguro T
    Seishin Shinkeigaku Zasshi; 1993; 95(1):1-29. PubMed ID: 7685527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sampling issues of cerebrospinal fluid and plasma monoamines: Investigation of the circadian rhythm and rostrocaudal concentration gradient.
    Janssens J; Atmosoerodjo SD; Vermeiren Y; Absalom AR; den Daas I; De Deyn PP
    Neurochem Int; 2019 Sep; 128():154-162. PubMed ID: 31034914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF.
    Nikisch G; Baumann P; Wiedemann G; Kiessling B; Weisser H; Hertel A; Yoshitake T; Kehr J; Mathé AA
    J Clin Psychopharmacol; 2010 Oct; 30(5):496-503. PubMed ID: 20814316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRH stimulation test and depression.
    Peabody CA; Whiteford HA; Warner MD; Faull KF; Barchas JD; Berger PA
    Psychiatry Res; 1987 Sep; 22(1):21-8. PubMed ID: 2443941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of idebenone on monoamine metabolites in cerebrospinal fluid of patients with cerebrovascular dementia.
    Kawakami M; Itoh T
    Arch Gerontol Geriatr; 1989 May; 8(3):343-53. PubMed ID: 2475076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in CSF concentrations of thyrotropin-releasing hormone in depressed patients and normal subjects: negative findings.
    Roy A; Wolkowitz OM; Bissette G; Nemeroff CB
    Am J Psychiatry; 1994 Apr; 151(4):600-2. PubMed ID: 7511876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.